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Abstract: Health disparities associated with severe mental illness (SMI) have become a major public
health concern. The disparities are not directly due to the SMI. They involve the same leading
causes of premature death as in the general population. The causes of the disparities are therefore
suspected to reflect differences in health-related behavior and resilience. As with other problems
associated with SMI, studying non-clinical populations at risk for future onset provides important
clues about pathways, from vulnerability to unhealthy behavior and compromised resilience, to
poor health and reduced quality of life. The purpose of this study was to identify possible pathways
in a sample of public university students. Four domains of biosystemic functioning with a priori
relevance to SMI-related vulnerability and health disparities were identified. Measures reflecting
various well-studied constructs within each domain were factor-analyzed to identify common sources
of variance within the domains. Relationships between factors in adjacent domains were identified
with linear multiple regression. The results reveal strong relationships between common factors
across domains that are consistent with pathways from vulnerability to health disparities, to reduced
quality of life. Although the results do not provide dispositive evidence of causal pathways, they
serve as a guide for further, larger-scale, longitudinal studies to identify causal processes and the
pathways they follow to health consequences.
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1. Introduction
Health disparities are widespread among people with serious mental illness (SMI),
resulting in a life expectancy some 20 years shorter than the general population [1–6].
Serious mental illness (SMI) is a broad classification of a diagnosable mental, behavioral, or
emotional disorders characterized by serious and disabling functional impairment that
typically limits one or more of an individual’s life activities [7]. The health disparities in
SMI are not attributable to the psychiatric disorder itself, but rather to the major causes of
death in the general population, including heart and vascular disease, respiratory disease,
cancer, and diabetes [1,5,8–12]. Accordingly, the medical and public health interventions
most successful in reducing mortality in the general population also show promise in
the SMI population, despite them being inequitably provided to this uniquely vulnerable
population [9,13–15]. These findings have stimulated interest in the relationships between
psychiatric disorders and health-related behaviors (physical activity, sleep, diet, smoking,
etc.) that are often the targets of preventive interventions in other populations but are at
times overlooked in treatment of SMI, since the primary treatment focus in this population
tends to be psychiatric in nature. Additionally, problems more characteristic of SMI but
suspected of contributing to health disparities, such as vulnerability to stress, sleep disturbance, and social isolation, are of special interest in designing specialized intervention
strategies [16–32].
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Background
Risk and vulnerability research in schizotypy. The health disparities issue extends beyond
people with psychiatric disorders to people with vulnerabilities that create a risk for the
eventual onset of a disorder. Of particular interest with respect to SMI are vulnerabilities
of genetic origin, generally understood to be endophenotypes; vulnerabilities with other
prenatal origins, e.g., from toxic or infectious factors that are present at birth; and those
with origins in childhood adversity, such as abuse and neglect. All three disrupt normal
development, resulting in impaired cognitive functioning, self-regulation, and socialization.
The construct of schizotypy has been a focus of research on such vulnerabilities because it is
understood to reflect a state of vulnerability to and risk for the onset of schizophrenia in
late adolescence and early adulthood [33–38].
Domains of biosystemic functioning. Four particular domains of biosystemic functioning
relevant to health disparities emerged from the existing background literature and provided
the framework for guiding instrument selection and organization of this study’s analyses:
(1) vulnerabilities present at birth or acquired in early childhood; (2) skills and abilities
associated with resilience to psychological and physical stress, acquired in later childhood,
adolescence, and early adulthood; (3) psychological and physical health; and (4) quality of
life. The domain of resilience logically divides itself into two subdomains: psychological
resilience and healthy behavioral habits and lifestyle. Health logically divides itself into
three subdomains: physical health, psychological health, and sleep (which has both physical
and psychological components). Quality of life logically divides itself into two subdomains:
psychological well-being and social connectedness. Within each domain or subdomain,
multiple measurable constructs from previous research were entered into factor analyses to
construct variables reflecting key sources of variance for further analysis. Eventually, largescale longitudinal studies of vulnerable populations will be necessary to fully understand all
the mechanisms of the effects of psychiatric disorders on health disparities, and in turn, the
effects of health on quality of life. Meanwhile, identification of the underlying dimensions
of those mechanisms, as revealed by canonical factors of vulnerability, resilience, health,
and quality of life, provide important clues about the pathways of particular vulnerabilities
toward the real-world consequences we observe.
Current research gaps in SMI vulnerability. Most previous research on vulnerability
to SMI has been within specific theoretical contexts: on the construct of schizotypy, the
role of cognitive impairments, etc. This approach reveals specific etiological processes
that link congenital vulnerabilities and vulnerabilities acquired in early childhood to later
development, e.g., in mood/emotion regulation and socialization. However, in the real
world, overall vulnerability includes multiple causal, mediating, and moderating constructs.
Studies of the roles of specific vulnerability constructs in personal and social functioning
and health disparities provide only one piece of the total picture at a time.
This methodological problem is compounded by the inevitability of multiple domains
of measurement in health disparities research. Physical health is influenced by multiple factors operating at all levels of biosystemic functioning—physiological, cognitive, behavioral,
social, and environmental.
Purpose of study. The purpose of this study was to create a set of canonical variables
which incorporate diverse constructs that have proven useful in previous vulnerability
and health disparities research, suitable for studying processes across multiple domains of
biosystemic functioning, and across progressive stages of human development. In contrast
to research questions about the contributions of specific constructs to health disparities,
such as schizotypy and other developmental vulnerabilities, the question addressed by
the canonical approach is, “What are the common elements, across multiple paradigms
and constructs, that create pathways, from genetic and acquired vulnerabilities, to the
behavioral and lifestyle patterns known to expose or protect people from health risks, to
actual psychological and physical health, and to the circumstances and experiences that
determine a person’s quality of life?” The answers to this question complement the findings
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from focused studies of particular constructs, to provide a complete picture of the causes of
health disparities and their potential solutions.
Aims/significance. Joint consideration of factors within these respective domains and
subdomains can create a manageable set of operational measures needed to portray an
integrated view of processes that lead from vulnerability to pathology, to health disparities,
to compromised quality of life. A comprehensive empirical analysis of all the relationships
and pathways involved is methodologically feasible, through the application of advanced
multivariate modeling methods. Such methods have demonstrated usefulness in studying
vulnerability in the general population (e.g., Stinson et al. [39], this issue), but application
to relatively small subpopulations, such as people vulnerable to SMI, is made difficult
by the requirement for very large subject samples. Additionally, complete validation of
the cause–effect relationships that multivariate modeling can reveal ultimately requires
longitudinal research designs. The present study represents the initial stage of a large-scale
longitudinal project designed for that purpose. The dataset for this study was the “Time
1” component of longitudinal data collection that will continue for several more months.
This cross-sectional dataset is not suitable for complete modeling analyses, but it is suitable
for the determination of the underlying dimensions within key domains and subdomains
pertinent to psychopathology and health disparities. In addition, simple linear multiple
regression analyses can provide an initial indication of possible causal relationships across
domains, leading ultimately to health disparities and their consequences on quality of life.
These analyses generate key hypotheses to guide subsequent modeling analyses capable of
validating causal relationships.
Factor analysis and simple linear regression used in this context do not lend themselves
to specific hypotheses, as expected for experimental research. Nevertheless, the expected
findings can be expressed in quasi-hypothetical terms. In that sense, the hypothesis of this
study is that multiple measurement paradigms based on previously validated constructs
within a priori domains of biosystemic functioning and measurement reflect underlying
common dimensions, whose relationships with common dimensions in other relevant
domains can be quantitatively measured. Support of this hypothesis is a step toward a
comprehensive understanding of the role of vulnerability to SMI in health disparities and
their consequences on quality of life.
Study population sample. The subject population of the present study is students
attending colleges and universities in the United States of America. College and university
students are frequently used in vulnerability and health research, and not only because they
represent a convenient and accessible subject population. College populations are relatively
homogenous, compared to the general population, with respect to socioeconomic status,
living conditions, and levels of personal and social functioning. This is advantageous for
studying vulnerabilities in a context less confounded by those factors. Additionally, college
students are generally in the middle of the onset risk window for schizophrenia, allowing
for observation of vulnerability factors as they are expressed after a full period of child
and adolescent development, but before the onset of frank psychosis. There is a surprising
degree of variability in measures of vulnerability in this subpopulation. College and
university students are not necessarily representative of vulnerable individuals in different
settings or contexts; however, important subpopulations parallel various characteristics,
vulnerabilities, and resilience factors found outside of college student populations. It is
probably not feasible to assemble a subject sample that matches the college and university
population in all pertinent demographic and socioeconomic characteristics except for
student status. Pathways from vulnerability to health disparities to quality of life may have
unique features in college and university students, but the same must be expected of other
subpopulations. Both the common features and the unique features are of scientific interest.
The present study articulates features of the college and university subpopulation, and
further research will articulate the extent to which the features are unique or common with
other vulnerable subpopulations. Understanding both the unique and the common features
of any subpopulation will be necessary to fully address the problem of health disparities.
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2. Methods
2.1. Participants and Procedures
Data for this study represent the initial stage of a large-scale longitudinal research
project. The entire project is under the oversight of the University of Nebraska—Lincoln’s
Institutional Review Board. The full longitudinal project includes a series of seven surveys
that span five waves of data collection. Continued data collection for the full longitudinal
project is currently underway.
The participants are undergraduate and graduate students attending a large public
university in the American Great Plains. Recruitment procedures were designed to (1) take
advantage of routine mechanisms for recruiting research participants as part of required
coursework, and (2) extend catchment beyond course-related mechanisms to include a
broader and more representative sample of university students. Participants were recruited
through e-mails sent to students who had previously participated in the university psychology department’s research subject pool and indicated interest in other opportunities
to participate in research, a series of recruitment e-mails sent across multiple university
listservs reaching various student subpopulations, and posting a recruitment solicitation in
the university honors program newsletter. A stratified recruitment strategy was employed,
emphasizing listservs and other sources expected to disproportionately access individuals
with chronic physical and psychological health conditions and disabilities. Compensation
was provided as either course credits or Amazon e-gift cards, or a combination of the two,
according to each participant’s choice. In addition, participants who completed all phases
of data collection were entered into a lottery to win one of four Amazon Fire Tablets.
Participant inclusion criteria were (1) age between 18 and 35, (2) currently living in
the United States, (3) able to speak and read English, and (4) have access to the online
questionnaires via computer. Participants confirmed their consent online by responding to
the IRB-approved consent form, presented at the beginning of the first set of questionnaires.
A total of 213 individuals completed the study protocol, with missing data being randomly
distributed. Listwise deletion for missing data was used for all factor and regression
analyses, resulting in Ns for specific analyses ranging from 213 to 190.
2.2. Measures
The measures selected for this study include both reflective and formative measures [40]. Reflective psychometric measures reflect an underlying psychological construct,
thereby requiring confirmation of interitem reliability in the form of Cronbach’s alpha. Formative measures are not psychometric, do not necessarily reflect an underlying construct,
and are simple cumulative tallies of items not necessarily expected to be intercorrelated—
reliability lies in the accuracy of reporting, in this case self-reporting. Interitem reliability
is irrelevant.
All reflective measures with 10 or more items used in this study demonstrated “acceptable” to “excellent” reliability in the present study’s dataset, as measured by Cronbach’s
alpha of 0.7 or above. For reflective measures comprised of less than 10 items that did not
demonstrate acceptable reliability via a Cronbach’s alpha of 0.7 or above, a combination
approach of examining Cronbach’s alpha and interitem correlations was utilized, since
interitem correlations are a better method of evaluating internal consistency than alpha for
scales comprised of few items with correlations exceeding r = 0.15 being deemed acceptable [41]. Inclusion criteria for those measures in this study were a Cronbach’s alpha of at
least 0.5, in addition to an interitem correlation of between r = 0.15 and r = 0.50.
The integrity of all the data was protected by items in the data collection protocol
that detected inattention or random responding, e.g., items such as “Please choose ‘3’
(Applied to me very much or most of the time) so we know you are still following along.”
Participants’ data were excluded from the dataset if during the third baseline survey they
(a) missed more than one of the attention-check validity items indicating inattentive or
random responding or (b) they missed one of the attention-check validity items indicating

Behav. Sci. 2022, 12, 240

5 of 26

inattentive or random responding and their survey duration was under 70% of the average
survey completion time.
Demographics. A basic demographics survey collected information about participants’
race, ethnicity, sex at birth, age, marital status, socioeconomic background, childhood
environmental urbanicity, medical history of diagnosed chronic health condition(s), individual/family psychiatry history, and disability.
Developmental vulnerabilities domain. The construct of schizotypy consists of a set of traits
that are qualitatively similar to features of schizophrenia spectrum disorders and fall along
a continuum of severity in normative populations [42]. Schizotypy is considered a vulnerability for schizophrenia spectrum disorders [37]. Like schizophrenia, schizotypy includes
three categories of symptoms and related features, positive, negative, and disorganized [38].
Each category can be measured on a continuous dimension of severity, and schizotypy can
be understood as a profile of the three dimensions. In addition to genetic and anatomical
links, clinical and subclinical expressions of psychosis are associated with psychosocial
factors, including urbanicity, poverty, discrimination associated with minority status, immigration, poor parental communication, poor parental care, and various types of childhood
adversity, such as abuse, neglect, and bullying [34,43]. Schizotypy is associated with impairment in social competence, rapport with family and friends, interpersonal engagement,
social and recreational activity, and occupational and academic functioning [33,36]. Many
of the social cognition and social functioning deficits observed in nonclinical groups are
thought to predate and predict the onset of the frank disorder [35,44].
A second construct implicated in developmental vulnerability is emotion regulation,
which denotes abilities that develop in early- to mid-childhood that serve to regulate and
control processes in the central and autonomic nervous system associated with emotional
reactivity and behavioral activation. Emotion regulation involves both neurophysiological
and psychological components, the control of neurophysiological and primitive psychological processes by higher cognitive processes, and is generally understood to lie in the
psychophysiological domain of biosystemic functioning. Distress tolerance and alexithymia
are operationally measurable constructs implicated in impairment or disruption of the
normal development of emotion regulation, and have been extensively studied in the
context of psychopathology and vulnerability.
Distress tolerance is a type of emotional regulation: the ability to maintain functioning
despite elevated personal distress. Deficits in distress tolerance and related processes
are observed in schizophrenia spectrum disorders [45–47]. Alexithymia is a decreased or
absent ability to label and describe one’s own emotional state [48], which is of interest in
clinical research due to its significant relationship with psychopathology and association
with social dysfunction [49–51]. Elevated levels of alexithymia have been observed in
schizophrenia populations [52,53] and individuals high in schizotypal traits [48,50,54].
A third construct that has received much recent attention in vulnerability research is
childhood adversity. An extraordinary proportion of people with SMI have histories of child
maltreatment [55]. People who have experienced maltreatment as children are at elevated
risk for psychiatric disorders, including suicidality [56–58]. Among people diagnosed
with schizophrenia, child maltreatment history is associated with greater disability [59].
This is consistent with links between trauma and psychosis in adults [60] and high-risk
children [61]. More broadly, poverty brings a panoply of childhood adversities, and
those adversities are found disproportionately in the histories of people diagnosed with
schizophrenia [62].
Developmental domain: Schizotypy. The 77-item self-reported Multidimensional Schizotypy Scale (MSS [37]) was used to assess schizotypy. The MSS consists of positive, negative,
and disorganized subscales that allow it to measure multidimensional schizotypy. The
MSS is a newer measure of schizotypy using updated question wording to reliably measure positive, negative, and disorganized features of schizotypy that better capture the
heterogeneity of schizotypal presentations. Higher scores across the three domains indicate
greater endorsement of the corresponding schizotypal features. The ranges are 0–26 for
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positive, 0–26 for negative, and 0–25 for disorganized schizotypy. The MSS-77 has demonstrated excellent internal consistency reliability with both Cronbach’s alpha and binary
alpha methods, and good construct validity [37].
Developmental domain: Alexithymia. The 20-item self-reported Toronto Alexithymia
Scale (TAS-20 [63]) was used to assess alexithymia. It includes three subscales, measuring
difficulty identifying one’s own feelings, difficulty describing one’s own feelings, and
externally-oriented thinking [63]. Participants rate their agreement with items on a 5-point
Likert-type scale. Possible scores range from 20 to 100. Higher scores reflect greater degrees
of alexithymia. The TAS-20 has demonstrated good internal consistency and test–retest
reliability [63]).
Developmental domain: Distress tolerance. The 15-item self-reported Distress Tolerance
Scale (DTS [64]) was used to assess an individual’s ability to tolerate feelings of emotional
distress; it has subscales that capture several dimensions of distress tolerance, including
tolerance, absorption, appraisal, and regulation [64]. Participants are asked to think about
times they feel upset or distressed and are then asked to rate how strongly they agree or
disagree with a given statement on a scale of “1” (strongly agree) to “5” (strongly disagree).
Possible scores range from 15 to 75. Higher scores reflect greater tolerance of distress.
The DTS has demonstrated good test–retest reliability, internal consistency, and construct
validity [64].
Developmental domain: Childhood adversity. The 28-item self-reported Childhood Trauma
Questionnaire (CTQ [65]) was used to assess lifetime history of childhood physical, emotional, and sexual abuse. Participants are asked to rate how often each statement applies
to them on a scale of “1” (never true) to “5” (very often true). Possible scores range from
28 to 140. Higher scores reflect higher experiences of trauma during childhood. The CTQ
has demonstrated good test–retest reliability and convergence and discrimination [66].
Psychological resilience subdomain. Beliefs, attitudes, and related traits have long been
studied as moderators of health in general, and of psychiatric disorders in particular. Loci
of control paradigms applied to health, such as beliefs about the importance of health
relative to other personal issues and the degree of personal control one can have over
one’s own health, provide quantitative measures of those beliefs. People with SMI express
beliefs in this domain consistent with poorer health [67] and predictive of a more disabling
course of the disorder [68]. Other familiar psychological constructs understood to provide
resilience and counteract vulnerability include self-efficacy, self-esteem, self-concept, and
a sense of purpose in life. More recently, new constructs, such as mindfulness [69], grit
(persistence and personal initiative [70]), and metacognitive awareness [71], have become
candidates for providers of resilience in the face of vulnerability and illness.
Psychological resilience subdomain: Sense of purpose. The 14-item self-reported Sense of
Purpose Scale (SOPS-2 [72]) was used to assess the extent to which individuals believe
their lives have purpose. Subscales include awareness of purpose, awakening to purpose,
and altruistic purpose. Participants were asked to rate the degree to which they agree or
disagree with each statement on a scale of “1” (strongly disagree) to “7” (strongly agree).
Scores range from 14–98. Higher scores reflect a stronger sense of purpose. The SPS has
shown construct reliability and criterion validity across all three subscales [73].
Psychological resilience subdomain: Self-esteem. The 10-item self-reported Rosenberg
Self-Esteem Scale (RSE; [74]) was used to assess self-esteem. Participants were asked to
rate how much each statement regarding their self-esteem applies to them on a scale of
“1” (strongly agree) to “4” (strongly disagree). Total scores range from 10 to 40; higher
scores represent lower self-esteem. The RSE has shown excellent internal consistency and
test–retest reliability and concurrent, predictive, and construct validity [74].
Psychological resilience subdomain: Grit. The 12-item self-reported GRIT Scale (GRIT-12; [70])
was used to assess passion and perseverance for long-term goals. Participants are asked to
rate how much each statement applies to them from “1” (very much like me) to “5” (not
like me at all). Scores range from 12–60. A higher total score reflects a greater degree of grit.
The GRIT-12 has shown predictive and convergent validity and internal consistency [70].
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Psychological resilience subdomain: Self-efficacy. The 10-item self-reported General SelfEfficacy Scale was used to assess an individual’s perception of self-efficacy. Participants
were asked to rate how true each statement is on a scale of “1” (not at all true) to “4” (exactly
true), with total scores ranging from 10–40. Higher scores reflect greater sense of self-efficacy.
The GSE has demonstrated good internal reliability and criterion-related validity [75].
Psychological resilience subdomain: Self-Concept clarity. The 12-item self-reported SelfConcept Clarity Scale (SCCS [76]) was used to assess the extent to which an individual’s
self-beliefs are clearly and confidently defined, internally consistent, and temporally stable.
Participants were asked to rate the extent to which they agree with a series of statements
ranging from “1” (strongly disagree) to “5” (strongly agree). Total scores range from
12–60. Higher scores reflect greater self-concept clarity. The SCCS has demonstrated good
interrater reliability and criterion validity [76].
Psychological resilience subdomain: Mindfulness. The 39-item self-reported Five Facet
Mindfulness Questionnaire (FFMQ [69]) was used to assess trait dispositional mindfulness across five dimensions, including observing, describing, acting with awareness, nonjudging of inner experience, and non-reactivity to inner experience. Participants were asked
to rate the extent to which 39 statements were generally true to them from “1” (never or very
rarely true) to “5” (very often or always true). Higher scores reflect greater mindfulness.
The FFMQ has demonstrated good test–retest reliability and internal consistency and a
clear factor structure [69].
Psychological resilience subdomain: Metacognition. The 30-item version of the selfreporting Metacognitions Questionnaire (MCQ-30 [71]) was used to assess beliefs about
worry and people’s awareness of their own thought processes, capturing the individual differences across five important factors in the metacognitive model of psychological disorders,
including cognitive confidence, positive beliefs about worry, cognitive self-consciousness,
negative beliefs about the controllability of thoughts and danger, and beliefs about the need
to control thoughts. Participants were asked to respond to statements from “1” (do not
agree) to “4” (agree very much). Higher scores reflect greater metacognition. The MCQ-30
has demonstrated acceptable-to-good test–retest reliability and good internal consistency
and convergent validity [71].
Psychological resilience subdomain: Locus of control. The 24-item self-reported Internality,
Powerful Others, and Chance Scale (IPOCS-24 [77]) was used to assess a person’s perception
of internal control, chance, and powerful others. Participants were asked to respond to
statements from “1” (strongly disagree) to “6” (strongly agree). Subscale scores range from
0 to 48. Higher scores reflect greater standing in internal control, chance, and powerful
others dimensions. The three-factor approach used in this study has demonstrated the
best fit for Levenson’s locus of control model [78]. However, the “Internality” subscale
failed to meet the reliability criteria for inclusion in this study and was excluded from
further analyses.
Behavioral resilience subdomain. The domain of “healthy habits” has long been associated
with resilience to physical illness. Meanwhile, unhealthy habits, such as smoking, immoderate
use of alcohol, poor diet and nutrition, and lack of exercise, are notoriously over-represented
in SMI populations, an association which has recently been empirically confirmed [79–82].
Unhealthy habits and lifestyles are largely unexplored in vulnerable populations, but some
findings suggest they are elevated in at least some subpopulations [83].
Behavioral resilience subdomain: Health attitudes and behaviors. The 42-item self-reported
Lifestyle and Habits Questionnaire-Brief (LHQ-B [84]) was used to assess individuals’
attitudes and health behaviors. The full measure consists of several subscales assessing
an individual’s attitudes and behaviors in regard to different areas of life (e.g., physical
health, psychological health, social life, and nutrition). For the purpose of this study, three
subscales were used to assess attitudes and behaviors across domains: physical health,
nutrition, and exercise. Participants were asked to rate how strongly they agree or disagree
with a given statement on a scale of “1” (strongly disagree) to “5” (strongly agree). Subscale
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scores range from 4 to 30. Higher scores reflect greater self-reported health and nutrition.
The LHQ-B has demonstrated good test–retest reliability and construct validity [84].
Behavioral resilience subdomain: Diet. The 19-item self-reported Dietary Screener Questionnaire (DSQ [85]) was used to capture persons’ dietary habits by asking participants
about the different types of food and drinks they ingested over the past thirty days. For
each type of food or drink, respondents were asked how often they ate or drank it in the
past 30 days. Some questions also asked respondents to specify the type of food or drink
they ingested. For the purpose of this study, formative variables were constructed corresponding to the different components of the food pyramid to get a better understanding
of participants’ general eating habits across primary domains, including vegetables, fruit,
leafy greens, grains, sugary food, meat, and dairy.
Behavioral resilience subdomain: Smoking and drinking. The Alcohol and Substance Use
Frequency measure (ASUF) was created as a modification of the 7-item self-reported Drug
Use Frequency measure (DUF [86]) to include language updates and additional items
to better capture potential prescription and recreational substances for the present day.
Updates in the ASUF include the addition of several items that assess the frequencies of
substances that were not originally included in the DUF (e.g., Kratom, Kava Kava, Delta
8 THC) and the separation of items into sub-substance use categories (e.g., heroin separated
from other opioids). Subscale dimensions were also added to assess the biopsychosocial
nature of substance use, including the surrounding environment in which the substance was
used (e.g., home, party, and concert), and with whom the substance was used (e.g., alone,
significant other, friends, family, or strangers). Alcohol consumption items from the Alcohol
Use Frequency Measure (AUF) were combined with items from the DUF in the creation of
the Alcohol and Substance Use Frequency measure (ASUF). For the purpose of this study,
only three items representing formative constructs were included to assess participants’
frequencies of alcohol consumption, nicotine use, and cannabis use. Participants were
asked to report their frequencies of use of a series of substances on a scale of “0” (never)
to “5” (daily). All nicotine use, including smoking tobacco, smokeless tobacco (including
electronic nicotine delivery systems), and other nicotine products (e.g., chewing tobacco
and dip) were combined into a single variable assessing the frequency of nicotine use.
Physical health subdomain. Assessment of physical health in the general population
also requires a broader scope than in clinical populations, to include more than formally
diagnosed medical disorders. This involves inventories of the presence, frequency, and
severity of physical symptoms, plus measures of the distress associated with the symptoms.
Physical health subdomain: Physical symptoms distress. The 33-item self-reported CohenHoberman Inventory of Physical Symptoms (CHIPS [87]) was used to assess the occurrence
and disturbance related to physical symptoms. Participants are asked to choose from a scale
of “0” to “4” how much each symptom bothered or distressed them in the last two weeks.
The total score ranges from 0 to 132. Higher scores indicate greater distress associated
with physical health symptoms. The CHIPS has demonstrated reliability and moderate
validity [87,88].
Physical health subdomain: Physical symptoms report. A 24-item self-reported Physical Symptoms Report was used to assess an individual’s experience of physical health
symptoms (e.g., poor appetite or hands trembling). Participants were asked to select the
frequency with which they experience 24 physical health symptoms on a scale of “0” (not at
all) to “3” (daily). The total scores range from 0 to 72. Higher scores reflect higher experience
of physical health symptoms. This construct was created by modifying a health-symptom
frequency item from the Alcohol Use Frequency and Drug Use Frequency Measure’s health
subsection. The Physical Symptoms Report’s Cronbach’s alpha was 0.848, demonstrating
good scale reliability.
Physical health subdomain: Sickness behaviors. The 10-item self-reported Sickness Questionnaire (SQ-10 [89]) was used to assess sickness behaviors, or symptoms that typically
arise after inflammatory activation. Participants are asked to choose an answer to a series
of ten statements assessing common behaviors associated with inflammatory activation on
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a scale of “0” (disagree) to “3” (agree). The total scores range from 0 to 30. Higher scores
reflect greater perceived sickness behavior. Example items include, “I want to keep still,”
“I wish to be alone,” “I don’t wish to do anything at all,” and “My body feels sore.” The
SQ-10 has demonstrated adequate reliability, validity, and sensitivity to change [89].
Sleep subdomain. Sleep problems are of increasing interest with respect to a broad range
of psychological ill-health in clinical, non-clinical, and high-risk populations [25,90,91],
and especially in adolescents at high risk for schizophrenia. Sleep problems take many
forms, including sleep onset difficulty associated with anxiety, stress or rumination, early
awakening, nightmares, and chronic insomnia. Assessment requires identification of the
quality of the sleep, which includes both the severity of sleep problems and their impacts
on daytime functioning.
Sleep subdomain: Insomnia-specific rumination. The 20-item self-reported Daytime Insomnia Symptom Response Scale (DISRS [92]) was used to assess insomnia-specific rumination.
Participants were asked to indicate their frequencies of engagement in a series of behaviors
when they are feeling tired on a scale of “1” (Almost Never) to “4” (Almost Always),
with the total scale score ranging from 20 to 80. Higher scores indicate higher levels of
insomnia-specific rumination. Example items include, “Think about how hard it is to
concentrate”; “Think, I cannot be around people when I’m feeling this way”; and “Think
about how tired you feel.” The DISRS has demonstrated excellent reliability and good
internal consistency [92].
Sleep subdomain: Sleep disturbance. The 7-item self-reported Insomnia Severity Index
(ISI-7 [93]) was used to assess sleep disturbance. Participants were asked to rate on a
5-point scale from “0” to “4” their severity of insomnia problem(s), satisfaction with sleep
patterns, interference with daytime functioning, noticeability of impairment on quality of
life, and worry/distress related to current sleep problems. Scores across ISI items were
summed to obtain a total score indicating the level of sleep disturbance experienced over
the past two weeks, with higher scores reflecting greater self-reported sleep problems.
The ISI has demonstrated good internal consistency, test–retest reliability, and concurrent
validity [93,94].
Sleep subdomain: Sleep-reactivity. The 9-item self-reported Ford Insomnia Response to
Stress Test (FIRST [95]) was used to assess sleep-reactivity, which is the likelihood that an
individual will experience sleep disturbance following various stress events/situations.
Participants were asked to rate how likely it is following a series of situations for them
to experience difficulty sleeping on a scale from “1” (not likely) to “4” (very likely). The
total scores range from 9 to 36. Higher scores reflect greater “stress-related” vulnerability
to sleep disturbance. The FIRST has demonstrated high reliability and good construct
validity [95].
Psychological health subdomain. Assessment of overall psychological health in a nonclinical population arguably requires a broader scope than in clinical populations, because
of the importance of less acute or more subtle distress that is often eclipsed by diagnosable
disorders. Accordingly, an assessment protocol must cover clinical and subclinical levels
of mood and emotion dysregulation, anxiety, stress, and cognitive difficulty, including
problems with memory and behavioral organization. Of recent particular interest are
attenuated psychotic symptoms, understood as milder versions of symptoms that would fulfill
diagnostic criteria for a psychotic disorder at more severe levels. Attenuated psychotic
symptoms may be present in the general population at surprisingly high levels [96], but
their presence in vulnerable populations is linked to the onset of psychotic disorders and
symptom expression after onset [97].
Psychological health subdomain: Mood symptoms. The 21-item self-reported Depression
Anxiety and Stress Scales (DASS-21 [98]) was used to assess depression and anxiety. The
complete measure consists of three scales looking at depression (e.g., “I felt that life was
meaningless” and “I felt that I had nothing to look forward to”), anxiety (e.g., “I experienced
breathing difficulty” and “I felt I was close to panic”), and tension/stress (e.g., “I found
it difficult to relax” and “I felt that I was using a lot of nervous energy”). The DASS-21
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has the ability to distinguish depression and anxiety, which are often highly correlated in
other scales, so the depression and anxiety subscales were selected for use in this study [99].
Participants were asked to rate how often each statement applied to themselves on a scale
of “0” (did not apply to me at all) to “3” (applied to me very much, or most of the time).
Higher scores reflect more severe depression and anxiety. The DASS-21 is a reliable and
valid measure assessing features of depression, anxiety, and tension/stress and has several
advantages over the 42-item version, such as having a cleaner factor structure that makes it
more easily interpreted than the original DASS [100].
Psychological health subdomain: Perceived stress. The 10-item self-reported Perceived
Stress Scale (PSS-10 [87]) was used to assess perceived stress. Participants were asked to
indicate how often, within the last month, they felt/thought about a series of statements
on a scale of “0” (never) to “4” (very often). The total scores range from 0 to 40. Higher
scores indicate greater severity of perceived stress. The PSS-10 has acceptable psychometric
properties that are superior to those of the PSS-14 and has been recommended for measuring
perceived stress in both research and clinical practice [101].
Psychological health subdomain: Psychological Health. The 42-item self-reported Lifestyle
and Habits Questionnaire-Brief (LHQ-B) was also used to assess individuals’ psychological
health via the psychological health subscale. Scores ranges from 0 to 35. Higher scores
reflect greater perceived psychological health.
Psychological health subdomain: Negative and positive affect. The 20-item self-reported
Positive and Negative Affect Schedule (PANAS-SF [102]) was used to assess how often
individuals have felt a number of emotions. Participants were asked to indicate the
extent to which they have felt each emotion on a scale of “1” (very slightly or not at all)
to “5” (extremely). Subscale scores range from 20 to 100. Higher scores reflect higher
levels of positive and negative affectation. Example items include “Interested,” Irritable,”
“Jittery,” and “Ashamed.” The PANAS-SF has demonstrated high internal consistency and
convergent and discriminant validity [102].
Psychological health subdomain: Attenuated negative psychotic symptoms. The 15-item
Motivation and Pleasure Scale-Self-Report (MAPS-SR-15 [103]) was used to assess the
motivation and pleasure domains of negative symptoms. Participants were asked how
much pleasure they have experienced from a number of activities in the past week on
a scale of “0” (no pleasure) to “4” (extreme pleasure), followed by how often they have
experienced pleasure from that activity on a scale of “0” (not at all) to “4” (very often).
The total scale score ranges from 0 to 60. Higher scores reflect greater severity of negative
symptoms. The MAPS-SR has demonstrated good internal consistency and convergent and
discriminant validity [103].
Psychological health subdomain: Attenuated positive psychotic symptoms. A modified
21-item self-reported Prodromal Questionnaire-Brief Version (PQB-21 [104]) was used to
assess the frequency of attenuated positive psychotic symptoms experienced by participants
over the last thirty days on a Likert scale from “0” (never) to “4” (daily), while not under
the influence of drugs, alcohol, or other medication. This measure has been modified
from the original version that examines the same psychotic-like experiences and related
distress using a true/false question format to present the statement versions of items that
were used in the original 92-item Prodromal Questionnaire-Likert Scale version to capture
frequencies of the experiences endorsed by participants. If a participant reported having
an experience in the past thirty days, they were presented with a follow-up question,
“When this happens, how frightened, concerned, or distressed do you feel?” which was
also answered on a Likert scale from “0” (not at all) to “4” (extremely). For the purpose of
this study, we used a continuous quantitative frequency score to capture the rate at which
participants reported experiencing attenuated positive psychotic symptoms over the past
thirty days. The total scores range from 0 to 84. Higher scores reflect higher experience of
attenuated positive psychotic symptoms. The original Prodromal Questionnaire (PQ-92) is
the most commonly used psychosis risk-screening instrument in the literature [105]. The
incorporation of distress in this measure improves the accuracy of screening by minimizing
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false positives [106]. Results from validity studies on the PQB-21 found it to be comparable
to the PQ-92, deeming it a good self-reported screener for selecting subjects to interview for
psychosis risk in secondary mental health care services [107]. The PQ-B single factor showed
adequate goodness of fit index, and the total frequency score demonstrated excellent
internal consistency in community-derived adolescents [99,108].
Psychological health subdomain: Attention and concentration. The 6-item Adult ADHD
Self-Report Screening Scale for DSM-5 (ASRS-5 [109]) was used to assess attention and
concentration. Participants were asked to rate how often they have felt and conducted
themselves in a series of ways over the past 30 days on a scale of “1” (never) to “5” (very
often). A continuous quantitative total summed scale score was created for the purpose
of examining participants’ levels of impairment in attention and concentration. The total
scale scores range from 0 to 74 based on the instrument’s assigned standardized scoring
instructions. Higher scores reflect greater impairment in attention and concentration. The
ASRS-5 has demonstrated excellent operating characteristics in classifying persons that met
diagnostic criteria for ADHD in general population and special treatment samples [109].
Psychological health subdomain: Working memory and inhibition. The 14-item self-reported
Adult Executive Functioning Inventory (ADEXI-14 [110]) was used to assess executive functioning, with a particular focus on working memory and inhibitory control. Participants are
asked to rate how much each statement describes them on a scale of “1” (definitely not true)
to “5” (definitely true). Subscale scores range from 5 to 45. Higher scores reflect greater
working memory and inhibition. The ADEXI has demonstrated high internal consistency
and adequate test–retest reliability [110].
Psychological well-being subdomain. Psychological well-being has long been understood
to be a multidimensional component of quality of life [111–113]. The dimensions include
perceptions of one’s own health, socialization, a sense of autonomy and mastery over one’s
immediate environment, a sense of ongoing personal growth, and self-acceptance.
Psychological well-being subdomain: Psychological well-being. The widely used 18-item selfreported Psychological Well-being Scale (PWS-18 [112]) was used to assess six dimensions
of psychological well-being, including autonomy, environmental mastery, personal growth,
positive relationships with others, purpose in life, and self-acceptance. Participants were
asked to rate how strongly they agree or disagree with a series of statements on a scale of
“1” (strongly agree) to “7” (strongly disagree). Subscale scores range from 3 to 21. Higher
scores reflect higher levels of psychological well-being. The Ryff Scales of Psychological
Well-Being have been found to be a valid and reliable measure of psychological wellbeing [114,115]. However, the “Purpose in life” subscale of this instrument failed to meet
reliability criteria for this study and was excluded from further analysis.
Psychological well-being subdomain: Participation limitations. The 13-item self-reported
Participation Scale-Short Form (PS-SF [113]) was used to assess limitations and restrictions
on social participation. This measure is commonly used in rehabilitation, stigma reduction,
and social integration programs. Participants were asked to respond to a series of questions
about their social participation, including how big of a problem that area is to the person on
a scale from “1” (no problem) to “5” (large). Total scores range from 0 to 90. Higher scores
reflect greater restriction. The PS-SF demonstrated good validity and internal consistency
and was highly correlated with the full version of the Participation Scale, which supports
its construct validity [113].
Psychological well-being subdomain: Health-related quality of life. The 14-item self-reported
CDC “Health Days Measure” (CDC HRQOL [111]) was used to assess individuals’ perceived physical and mental health, including a subjective rating of their general health,
number of bad physical and mental health days, and number of days that their health
contributed to their inability to partake in routine activities over the past thirty days. Participants were asked to answer questions related to their health and its effects on their routines.
The HRQOL has demonstrated construct, criterion, internal, and concurrent validity and
test–retest reliability [110].
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Social connectedness subdomain. Social connectedness refers to persons’ general sense
of belonging and interpersonal closeness in their social world [116]. For the purposes of
this study, social disconnectedness is presumed to reflect the collective influence of socialcognitive and emotional self-regulation deficits on a person’s global social functioning,
especially the condition of his/her social support system.
Social connectedness subdomain: Loneliness. The 20-item self-reported Revised UCLA
Loneliness Scale Version 3 (UCLA-R V3 [117]) was used to assess subjective feelings of
loneliness and social isolation. Participants were asked to indicate how often each of the
statements was descriptive of them on a scale of “1” (never) to “4” (often). The total scores
range from 20 to 80. Higher scores reflect greater feelings of loneliness. Example items
include, “How often do you feel that you are ‘in tune’ with the people around you?”;
“How often do you feel that you lack companionship?”; and “How often do you feel left
out?” This version of the measure has been found to have high reliability in both internal
consistency and test–retest reliability over the period of one year, along with convergent
validity with other measures of loneliness [117].
Social connectedness subdomain: Social connectedness. The 20-item self-reported Social
Connectedness Scale-Revised (SCS-R [116]) was used to assess individuals’ general sense
of belonging and interpersonal closeness with the social world. This measure was selected
because many other widely used measures of social functioning include behavioral items
that were not appropriate given the context of the ongoing COVID-19 pandemic. Participants rated their agreement with items on a 6-point Likert-type scale. The total scores
range from 20 to 120. A higher total score reflects a greater degree of social connectedness.
Example items include “Even among my friends, there is no sense of brother/sisterhood”
and “I don’t feel related to anyone.” The SCS-R has demonstrated good convergent and
divergent validity, and internal consistency [116].
Social connectedness subdomain: Social support. The 12-item Multidimensional Scale of
Perceived Social Support (MSPSS [118]) was used to assess individuals’ perceived adequacy
of social support from three sources: friends, family, and a significant other. Participants
were asked to rate how strongly they agreed or disagreed with each statement on a scale of
“1” (very strongly disagree) to “7” (very strongly agree). Subscale scores range from 12 to 84.
Higher scores reflect greater perceived adequacy of social support. Example statements
include “There is a special person around when I am in need,” “My family tries to help
me,” “I get the emotional help and support I need from my family,” and “I can count on
my friends when things go wrong.” The SCS-R has demonstrated adequate internal and
test re-test reliability, strong factorial validity, and moderate construct validity [118].
2.3. Data Analysis
All data analysis was conducted with SPSS version 28.0.0.0.
A principal axis factor analysis was performed for all the selected measures within
each domain or subdomain. For the measures that generate subscales, all subscales that
met reliability criteria were included, but scales representing a total or summary score for a
single measure with multiple subscales were excluded (this was to reduce the influence on
the factor solutions of correlated subscales of a single instrument). There were thus 8 factor
analyses, reflecting the developmental domain; the psychological resilience and healthy
habits subdomains; the physical health, psychological health, and sleep subdomains; the
psychological well-being subdomain; and the social well-being subdomain. The standard
criteria for factor extraction were applied, an eigenvalue >1.0, with a maximum of 25 iterations for convergence. The extracted factors were subjected to direct oblimin rotation, to
allow for expected correlations between factors.
The resulting factors were arranged in an a priori sequence of causal influence across
domains, from developmental vulnerabilities to resilience, to health, to quality of life.
The participants’ computed factor scores were then subjected to simple linear multiple
regression analyses, wherein each factor score in turn was the dependent or “target”
variable (except for the developmental factors, assumed to be exogenous variables), and
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the factors in the sequentially prior domain were the independent variables. To control
for randomly missing data and non-normal distributions [119], parameter estimations
for the linear regressions were produced by bootstrapping (nonparametric resampling)
10,000 resamples with replacement.
3. Results
3.1. Demographics
The demographics and other sample characteristics are shown in Table 1. The demographics are consistent with expectations for a large public university in the U.S. Great
Plains. As expected, due to the stratified recruitment strategy, students with histories of
chronic medical conditions, mental health treatment, and disabilities are disproportionately represented.
Table 1. Sample demographics (N = 213).
Age (years), mean (SD) [range]

20.530 (2.804) [15]

Sex assigned at birth, N (%)
Female

173 (81.2%)

Male

40 (18.8%)

Race, N (%)
White or European America

177 (83.1%)

Black or African American

4 (1.9%)

Asian American

18 (8.5%)

American Indian or Alaska Native

2 (0.8%)

Native Hawaiian/Pacific Islander

2 (0.9%)

Other

10 (4.7%)

Ethnicity Hispanic/Latinx, N (%)

16 (7.5%)

Relationship status, N (%)
Single, never married

144 (67.6%)

Dating

53 (24.9%)

Committed relationship

67 (31.4%)

Married without children

2 (0.9%)

Married with children

2 (0.9%)

Average childhood household SES, N (%)
Less than $25,000

12 (5.7%)

$25,000 to $34,999

8 (3.8%)

$35,000 to $49,999

22 (10.4%)

$50,000 to $74,999

38 (17.9%)

$75,000 to $99,999

38 (17.9%)

$100,000 to $149,999

48 (22.6%)

$150,000 or more

46 (21.7%)

Urbanicity, N (%)
Rural

48 (22.5%)

Suburban

122 (57.3%)

Urban

43 (20.2%)
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Table 1. Cont.
Medical History, N (%)
Physician Diagnosed Chronic Health Condition

107 (50.2%)

Physician Diagnosed Sensory Impairment

87 (40.8%)

Psychiatric History, N (%)
Lifetime Psychotherapy

104 (48.8%)

Lifetime Inpatient Treatment

10 (4.7%)

Current Psychotropic Medication Use

72 (33.8%)

First-degree Genetic Family Autism Spectrum
Disorder

10 (4.7%)

Second-degree Genetic Family Autism
Spectrum Disorder

24 (11.3%)

First-degree Genetic Family Schizophrenia
Spectrum/Psychotic Disorder

4 (1.9%)

Second-degree Genetic Family Schizophrenia
Spectrum/Psychotic Disorder

7 (3.3%)

Participant Identified Disability, N (%)
No Disability (None)

114 (53.5%)

Medical/physical Disability

40 (18.8%)

Neurological Disability

21 (9.9%)

Cognitive

19 (8.9%)

Mental Health

65 (30.5%)

Other

2 (0.9%)

3.2. Factor Analyses
The results of the eight factor analyses across domains and subdomains are summarized in Table 2. A total of 17 factors were extracted. For clarity of interpretation, the
valences of correlations and loadings are shown as positive to indicate significant and/or
meaningful correlations in the expected direction, i.e., fewer vulnerabilities being associated with better health (in the initial output, the valences of the various correlations and
loadings were mixtures of positive and negative, because higher numbers reflect lower
vulnerability or better health for some measures, and the reverse for others). There were
no significant and/or meaningful valences in the unexpected or counterintuitive direction,
and therefore, no negative valences are shown in the table. Generally, as expected, the first
factor identified in the analyses accounted for 25% to 75% of the total variance within the
domain or subdomain and included all or most of the measures.
Table 2. Computed factors and loadings.
Developmental domain
Factor 1. Overall adversity and vulnerabilities: 30.4% *
Alexithymia Subscale “Describing”
Alexithymia Subscale “Identifying”
Schizotypy Subscale “Disorganized”
Alexithymia Subscale “Externally oriented”
Childhood trauma Subscale “Emotional abuse”
Childhood trauma Subscale “Emotional neglect”
Schizotypy Subscale “Positive”
Distress tolerance Subscale “Appraisal”
Distress tolerance Subscale “Absorption”

loadings
0.76
0.69
0.65
0.49
0.37
0.37
0.37
0.30
0.26
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Table 2. Cont.
Factor 2. Trauma and adversity: 12.7% *
Childhood trauma Subscale “Emotional abuse”
Childhood trauma Subscale “Emotional neglect”
Childhood trauma Subscale “Physical neglect”
Childhood trauma Subscale “Physical abuse”
Childhood household income
Schizotypy Subscale “Disorganized”
Distress tolerance Subscale “Absorption”
Alexithymia Subscale “Describing”
Alexithymia Subscale “Identifying”
Schizotypy Subscale “Positive”
Distress tolerance Subscale “Appraisal”
Factor 3. Vulnerability sans adversity: 10.0% *
Distress tolerance Subscale “Absorption”
Distress tolerance Subscale “Appraisal”
Alexithymia Subscale “Identifying”
Distress tolerance Subscale “Regulation”
Schizotypy Subscale “Disorganized”
Alexithymia Subscale “Describing”
Schizotypy Subscale “Positive”
Childhood trauma Subscale “Emotional abuse”
Childhood trauma Subscale “Emotional neglect”
Behavioral and psychological resilience domain
Psychological resilience subdomain
Factor 4. Overall resilience: 33.9% *
Sense of purpose Subscale “Awareness”
Self-esteem Scale
GRIT
Self-efficacy
Self-concept clarity
Sense of purpose subscale “Awakening”
Mindfulness Subscale “Acting with awareness”
Mindfulness Subscale “Describing”
Metacognition Subscale “Lack of confidence”
Internal powerful other Subscale “Internality”
Internal powerful other Subscale “Chance”
Internal powerful other Subscale “Powerful other”
Mindfulness Subscale “Nonjudgmental”
Sense of purpose Subscale “Altruistic purpose”
Metacognition Subscale “Negative beliefs”
Metacognition Subscale “Nonreactivity”
Metacognition Subscale “Need to control”
Factor 5. Worried metacognition: 11.7% *
Metacognition Subscale “Negative beliefs”
Metacognition Subscale “Need to control”
Mindfulness Subscale “Nonjudgmental”
Self-Concept Clarity
Self-esteem Scale
Metacognition Subscale “Self-consciousness”
Metacognition Subscale “Positive beliefs about worry”
Internal powerful other Subscale “Powerful other”
Metacognition Subscale “Lack of confidence”
Mindfulness Subscale “Describing”
Internal powerful other Subscale “Chance”
Metacognition Subscale “Nonreactivity”
Factor 6. Unreflective action: 7.3% *
Mindfulness Subscale “Observing”
Metacognition Subscale “Self-consciousness”
Metacognition Subscale “Nonreactivity”

0.86
0.79
0.73
0.68
0.39
0.39
0.30
0.30
0.30
0.25
0.25
0.88
0.87
0.57
0.56
0.49
0.37
0.37
0.33
0.32

0.77
0.75
0.74
0.69
0.68
0.66
0.63
0.62
0.57
0.53
0.52
0.52
0.50
0.45
0.44
0.38
0.26
0.66
0.65
0.62
0.56
0.49
0.49
0.39
0.36
0.35
0.33
0.32
0.28
0.58
0.48
0.46
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Table 2. Cont.
Self-efficacy
Sense of purpose Subscale “Altruistic purpose”
Self-esteem Scale
Mindfulness Subscale “Acting with awareness”
Behavioral resilience subdomain
Factor 7. Overall healthy habits: 25% *
LHQB Subscale: nutrition
Diet: veggies
Diet: fruit
diet: leafy greens
diet: grains
LHQB Subscale: Health & exercise
Factor 8. Smoking & drinking: 12.5% *
nicotine use
alcohol consumption
cannabis use
Factor 9. Sweet tooth: 11.8% *
diet: sugary foods
LHQB Subscale: nutrition
diet: fruit
diet: dairy
Health and illness domain
Physical health subdomain
Factor 10. Physical health: 63.1% *
CHIPS physical symptom distress
Physical symptoms report
Sickness questionnaire
Sleep subdomain
Factor 11. Sleep quality 64% *
Daytime Insomnia symptoms scale
Insomnia severity index
Ford stress insomnia scale
Psychological health subdomain
Factor 12. overall psychological health: 53.3% *
DASS Subscale: “Depression”
PSS Subscale: perceived stress
LHQB Subscale: “Psychological health”
DASS Subscale: “Anxiety”
PANA subscale: “Negative affect”
PANA subscale: “Positive affect”
MAPS total psychopathology
PQB attenuated psychotic symptoms
ADHD screener
AEFI Subscale: “Working memory”
AEFI Subscale: “Inhibition”
Factor 13. Cognitive difficulty: 12.0% *
AEFI Subscale: “Working memory”
AEFI Subscale: “Inhibition”
ADHD screener
PQB attenuated psychotic symptoms
LHQB Subscale: “Psychological health”
PSS Subscale: perceived stress
DASS Subscale: “Depression”
PANA subscale: “Negative affect”
PANA subscale: “Positive affect”
MAPS total psychopathology
Factor 14. Affective activation: 9.4% *
PQB attenuated psychotic symptoms
PANA subscale: “Positive affect”

0.32
0.28
0.27
0.26

0.73
0.70
0.65
0.61
0.52
0.50
0.68
0.40
0.35
0.50
0.42
0.32
0.31

0.90
0.87
0.65

0.69
0.68
0.67

0.89
0.85
0.80
0.78
0.76
0.75
0.74
0.60
0.54
0.45
0.30
0.88
0.87
0.54
0.54
0.51
0.46
0.45
0.42
0.42
0.28
0.51
0.49
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Table 2. Cont.
PANA subscale: “Negative affect”
DASS Subscale: “Anxiety”
MAPS total psychopathology
Quality of life domain
Psychological well-being subdomain
Factor 15. overall wellbeing: 44.0% *
Wellbeing Subscale: “Self-acceptance”
Wellbeing Subscale: “Mastery 1”
Participation scale
Wellbeing Subscale: “Personal growth”
Wellbeing Subscale: “Purpose in life”
Wellbeing Subscale: “Personal relations”
Bad mental health days
Wellbeing Subscale: “Mastery 2”
General health self-rating
Days of health restrictions
Factor 16. Health-related restrictions 14.6% *
Days of health restrictions
Bad physical health days
Bad mental health days
General health self-rating
Wellbeing Subscale: “Mastery 1”
Wellbeing Subscale: “Self-acceptance”
Participation scale
Wellbeing Subscale: “Personal relations”
Social wellbeing subdomain
Factor 17. Social connectedness: 63.1% *
UCLA loneliness scale
Social connectedness scale
MSPSS Subscale: “Friends”
MSPSS Subscale: “Family”
MSPSS Subscale: “Significant other”

0.45
0.45
0.43

0.84
0.73
0.70
0.68
0.66
0.65
0.49
0.47
0.43
0.42
0.82
0.72
0.68
0.64
0.54
0.52
0.46
0.28

0.95
0.90
0.73
0.56
0.51

* Percent of variance accounted for by factor within the domain or subdomain.

Developmental domain. The 16 variables entered yielded an unrotated factor solution
that accounts for 53.2% of the variance within the domain. Three factors were identified. The
unrotated factors account for 30.4%, 12.7%, and 10.0% of the variance. Based on the rotated
structure matrix, the respective factors were labeled overall adversity and vulnerabilities,
trauma and adversity, and vulnerability sans adversity. The rotated factors are modestly
intercorrelated, from r = 0.23 to r = 0.30.
Psychological resilience subdomain. The 20 variables entered yielded an unrotated factor
solution that accounts for 52.9% of the variance within the subdomain. The unrotated
factors account for 33.9%, 11.7%, and 7.3% of the variance. Three factors were identified.
Based on the rotated structure matrix, the respective factors were labeled overall resilience,
worried metacognition, and unreflective action. The rotated factors are modestly intercorrelated,
from r = 0.18 to r = 0.28.
Healthy habits subdomain. The 12 variables entered yielded an unrotated factor solution
that accounts for 49.2% of the variance within the subdomain. The unrotated factors account
for 25.0%, 12.5%, and 11.8% of the variance. Three factors were identified. Based on the
rotated structure matrix, the respective factors were labeled overall healthy habits, smoking
and drinking, and sweet tooth. There are no meaningful correlations between the factors.
Physical health subdomain. The three variables entered yielded an unrotated factor
solution that accounts for 76.6% of the variance within the subdomain. Only one factor was
identified. Based on the unrotated factor matrix, it was labeled overall physical health.
Sleep subdomain. The three variables entered yielded an unrotated factor solution that
accounts for 64.0% of the variance within the subdomain. Only one factor was identified.
Based on the unrotated factor matrix, it was labeled sleep quality.
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Psychological health subdomain. The 11 variables entered yielded an unrotated factor
solution that accounts for 74.6% of the variance within the subdomain. Three factors were
identified. The unrotated factors account for 53.3%, 12.0%, and 9.4% of the variance. Based
on the rotated structure matrix, the respective factors were labeled overall psychological
health, cognitive difficulty, and affective activation. The only meaningful correlation between
factors was that of overall psychological health with cognitive difficulty (r = 0.48).
Psychological well-being subdomain. The 11 variables entered yielded an unrotated factor
solution that accounts for 59.0% of the variance within the subdomain. Two factors were
identified. Based on the rotated structure matrix, the factors were labeled overall well-being
and health-related restrictions. The unrotated factors account for 14.6% and 7.8% of the
variance, respectively. The two factors are meaningfully correlated (r = 0.44).
3.3. Regression Analyses
The results of the sequenced linear regression analyses are summarized in Figure 1.
The three factors in the developmental subdomain significantly predicted (in the statistical
sense; p < 0.05 for the R2 of the equation) four of the six factors in the behavioral and
psychological resilience domain. Four of the six behavioral and psychological resilience
factors contributed to prediction of all five of the factors in the health domain. Four of the
five health factors contributed to prediction of all three quality of life domains. The strength
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0% to 79% of the variance of the target factors. For the significantly predicted target factors,
one to four of the factors in the adjacent domain contributed uniquely to the prediction.
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To summarize the results, the factor analyses showed that common sources of variance,
could be identified within the domains and subdomains that do not simply reflect
4. factors,
Discussion
specific measures or the constructs or paradigms on which they are based. The sequential
The factor analyses were successful in identifying common sources of variance across
linear regression analyses showed that there are significant relationships between factors in
different
adjacentmeasures,
domains. derived from different constructs and paradigms, within their respec-

tive domains and subdomains. This supports the feasibility of a research approach that
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as associated with all five factors in the health domain; there were additional links to two or more
health domain factors by four of the six factors in the resilience domain. Overall resilience
was also fairly strongly associated with all three of the developmental factors, suggesting
it may represent an important common pathway between vulnerability and health dis-
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posits a generalized progression across multiple domains of biosystemic functioning, from
vulnerability states at birth or acquired in early childhood, to individual differences in
resilience, to health disparities, to compromised quality of life.
The regression analyses identified the overall psychological resilience factor as associated with all five factors in the health domain; there were additional links to two or
more health domain factors by four of the six factors in the resilience domain. Overall
resilience was also fairly strongly associated with all three of the developmental factors,
suggesting it may represent an important common pathway between vulnerability and
health disparities.
Healthy habits are weakly associated with affective activation and sleep quality, and
not at all with physical health. Smoking and drinking are not linked to any of the health
factors. This would seem to be counterintuitive but may reflect a key feature of the
university population, youthfulness. They may be too young for bad habits to affect their
health, yet. This may be an important consideration for continued research on health
disparities in vulnerable university populations. Additionally, although sleep quality is
associated with healthy habits, overall resilience, and worried metacognition, it is not in
turn linked to any quality-of-life factors. This may reflect a leveling effect of the myriad
sources of sleep irregularity and disruption in student life.
Physical health and psychological health are associated with different factors in the
quality of life domain. Physical health in this population is associated with health-related
restrictions on desirable and important activities, and with social connectedness, but not
with overall well-being, which is more strongly associated with psychological health factors. This may also be a feature of vulnerability in university students, who presumably
have better access to basic healthcare than other vulnerable populations. Additionally, the
culture and priorities of higher education provide sources of satisfaction and opportunities for achievement relatively insulated from health problems—e.g., being a successful
student—which are less available in other environments. In less supportive environments,
especially where poverty is more ubiquitous, the impact of physical ill health should
be expected to be less buffered. Nevertheless, it is important that even in the supportive university environment, poor health is still associated with activity restrictions and
social disconnectedness.
The pathways revealed by the regression analyses indicate that processes in the
intermediate domains identified in this study participate in the impacts of vulnerability on
health, quality of life, and social connectedness, but this is not an exhaustive account of all
possible pathways between developmental vulnerabilities, resilience factors, health, and
quality of life, even among the factors identified in this study. A larger-scale longitudinal
dataset using these variables will allow simultaneous evaluation of all possible pathways
between the factors identified in this study, including “direct” effects of each factor upon
the others, and “indirect” effects, mediated or moderated by intermediate factors. For
example, such an analysis would be expected to identify a “direct” effect of developmental
vulnerabilities upon quality of life, in addition to the “indirect” effects identified in this
analysis, via resilience and health. For practical purposes, the mechanisms of such “direct”
effects are unknown. They presumably consist of multiple “indirect” pathways, of which
the pathways identified in this study are a subset. In that sense, progress in understanding
the role of vulnerability in health disparities will be through the identification of all the
“indirect” pathways between the two. This could include domains and subdomains not
considered in the present study.
4.1. Limitations and Strengths
This study’s limitations include its cross-sectional nature, the sample’s use of college
students with an over-representation of disabilities corresponding to recruitment procures,
and use of self-reported data. While the cross-sectional nature of the study (data examined
at baseline timepoint) renders the path model results as illustrating preliminary findings
on various domains of vulnerability, resilience, health habits, and mental and physical
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health for informing health disparities research, it is within the context of a large-scale
longitudinal study with ongoing data collection. The longitudinal study will allow for
the follow-up examination of domains identified in this study via longitudinal structural
equation modeling, which could provide us with more information on direct and indirect
effects and allow us to disaggregate into between-person (i.e., person mean across the study;
Level 2) and within-person components (i.e., deviation from the person mean at a given
time point; Level 1) [120]. Additionally, the present study employed an analytic design that
measured the included constructs in a temporal, sequential, and developmental sequence.
Though some may find the use of a college student sample limiting, it is but a minor
limitation, as no matter what population, the same procedures would be used. Moreover,
this study’s unique recruitment procedures allowed for sample stratification by physical
health status, such that approximately half of the participants reported having at least one
physician-diagnosed chronic health condition. This enriched sample comprised of both
students with chronic health conditions and an otherwise physically healthy comparison
group provided helpful data for an examination of health disparities in a non-clinical,
emerging adult sample. While there would be no reason that the findings would generalize
to other populations, college students are not merely a “convenience sample” for schizotypy
research, especially in the context of health behaviors and outcomes. Adolescence and
early adulthood represent the peak age of onset for psychosis: 80% of first-episode psychoses occur between the ages of 16 and 30 [121,122]. Sleep disturbance is more prevalent
during this period, as demonstrated by 36% of college students reporting significant sleep
disturbances [123–125]. Thus, college students are of interest due to their demographics,
developmental stage, range of personal/social functioning, health behaviors, and other
characteristics, which highlight the value of better understanding how these dimensions
play out in this population sample and how they work differently in others. As within
all areas of science, best practice is to incorporate both non-clinical and clinical population samples to better understand theoretical progress, and models of vulnerability and
resiliency to inform research on health disparities.
This study’s unique methodological approach established a set of canonical variables
commonly utilized in vulnerability and health disparities research that may be suitable for
examining processes across multiple domains of biosystemic functioning and progressive
stages of human development. Thus, the research helped to identify some of the common
elements across multiple paradigms and constructs that create pathways spanning from
genetic and acquired vulnerabilities, to behavioral and lifestyle patterns contributing to
risk and resiliency in health, and ultimately to a person’s quality of life.
4.2. Future Directions
Consideration of existing findings on developmental vulnerabilities led to psychological constructs whose developmental courses are at least partially understood. Such
constructs are leading candidates for revealing common factors that ultimately impact
health disparities and quality of life. Eventually, large-scale longitudinal studies of vulnerable populations will be necessary to fully understand all the mechanisms of the effects
of psychiatric disorders on health disparities, and in turn, the effects of health on quality
of life. Meanwhile, identification of the underlying dimensions of those mechanisms, as
revealed by canonical factors of vulnerability, resilience, health, and quality of life, provide
important clues about the pathways of particular vulnerabilities toward the real-world
consequences we observe.
Thus, research must evolve in the direction of increasingly complex multivariate
analyses capable of evaluating multiple domains at different stages of development. One
strategy to progress from focused studies of particular constructs and processes to the bigger
picture in the real world is to empirically consolidate previously developed constructs into
manageable sets of canonical measures that reflect their key common components, within
broader domains of biosystemic functioning, with relevance to health disparities and the
factors that influence them.
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5. Conclusions
The approach to vulnerability and health disparities taken in this study complements
studies of more particular paradigms and constructs. For example, in a recent larger-scale
cross-sectional study in our research group [39], a focused analysis of the three dimensions
of schizotypy (positive, negative, and disorganized) revealed different pathways to social
connectedness, via developmental and psychological variables. The approach of the present
study provides a broad perspective on the involvement of major domains of measurement
and biosystemic functioning, whereas a focus on specific constructs within those domains
reveals particular causal mechanisms. Ultimately, an understanding of causal relationships
between particular constructs will be necessary for designing interventions to reduce or
prevent the impact of vulnerability and other aspects of mental health on health disparities.
Meanwhile, the approach of this study will helpfully identify all the domains and particular
constructs necessary to achieve an exhaustive and comprehensive account, and accordingly,
a complete intervention armamentarium.
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